Transforming breast cancer detection, ScreenPoint Medical’s Transpara Breast AI integrates seamlessly into Johns Hopkins Medicine’s renowned breast imaging services. This collaboration harnesses cutting-edge technology and clinical expertise to enhance screening accuracy and patient outcomes….
Continue Reading
An over-the-counter continuous glucose monitoring (CGM) solution developed by Dexcom called Stelo has received clearance from the Food and Drug Administration (FDA).Available without the need for a prescription, the wearable biosensor boasts a battery…
Continue Reading
What You Should Know:
DexCom, Inc. (NASDAQ:DXCM), the global leader in real-time continuous glucose monitoring for people with diabetes, announced today that the FDA has cleared Stelo by Dexcom – the first glucose biosensor that doesn’t…
Continue Reading
What You Should Know: Bone Health Technologies (BHT), a health technology innovator developing breakthrough non-invasive solutions for bone health, today announced the company has raised a new $5 million funding round from leading investment…
Continue Reading
Varian, a Siemens Healthineers company, has obtained FDA clearance for its TrueBeam and Edge radiotherapy systems featuring the innovative HyperSight imaging solution. This advancement aims to enhance treatment accuracy and minimize damage to healthy…
Continue Reading
Discover how Transpara Breast AI by ScreenPoint Medical revolutionizes mammography screening by providing radiologists with advanced support in cancer detection. Through real-world clinical studies presented at the European Congress of Radiology, learn how Transpara…
Continue Reading
What You Should Know:
– X-trodes, a pioneer in wireless monitoring solutions, has achieved a major milestone with the U.S. Food and Drug Administration (FDA) granting 510(k) clearance for its Smart Skin solution, marketed as…
Continue Reading
Merit Medical Systems has achieved FDA clearance for its groundbreaking SCOUT MD Surgical Guidance System, a significant advancement in breast cancer care. This innovative system enhances tumor localization with precise accuracy, reducing the need…
Continue Reading
Nanox’s HealthFLD, an AI-powered software, has received FDA clearance for automated analysis of liver attenuation from CT scans. This breakthrough technology facilitates early detection of fatty liver, aiding clinicians in diagnosing metabolic diseases. With…
Continue Reading
What You Should Know:
– 23andMe Holding Co. (Nasdaq: ME), a genetics and biopharmaceutical company, announced The U.S. Food and Drug Administration (FDA) has cleared the investigational new drug (IND) application for 23ME-01473 (referred to…
Continue Reading
